Evidence map›Paper›PMID 38020169›Full record

ArticleFrontiers in medicine2023

FibroVit-Vision transformer-based framework for detection and classification of pulmonary fibrosis from chest CT images.

Muhammad Waseem Sabir, Muhammad Farhan, Nabil Sharaf Almalki, Mrim M Alnfiai, Gabriel Avelino Sampedro

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Radiomics and Artificial Intelligence in Pulmonary Fibrosis.Journal of imaging informatics in medicine · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Muhammad Waseem SabirDepartment of Computer Science, COMSATS University Islamabad, Sahiwal, Pakistan.
Muhammad FarhanDepartment of Computer Science, COMSATS University Islamabad, Sahiwal, Pakistan.
Nabil Sharaf AlmalkiDepartment of Special Education, College of Education, King Saud University, Riyadh, Saudi Arabia.
Mrim M AlnfiaiDepartment of Information Technology, College of Computers and Information Technology, Taif University, Taif, Saudi Arabia.
Gabriel Avelino SampedroFaculty of Information and Communication Studies, University of the Philippines Open University, Los Baños, Philippines.
COMSATS University Islamabad · PKDe La Salle University · PHKing Saud University · SATaif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary Fibrosis (PF) is an immedicable respiratory condition distinguished by permanent fibrotic alterations in the pulmonary tissue for which there is no cure. Hence, it is crucial to diagnose PF swiftly and precisely. The existing research on deep learning-based pulmonary fibrosis detection methods has limitations, including dataset sample sizes and a lack of standardization in data preprocessing and evaluation metrics. This study presents a comparative analysis of four vision transformers regarding their efficacy in accurately detecting and classifying patients with Pulmonary Fibrosis and their ability to localize abnormalities within Images obtained from Computerized Tomography (CT) scans. The dataset consisted of 13,486 samples selected out of 24647 from the Pulmonary Fibrosis dataset, which included both PF-positive CT and normal images that underwent preprocessing. The preprocessed images were divided into three sets: the training set, which accounted for 80% of the total pictures; the validation set, which comprised 10%; and the test set, which also consisted of 10%. The vision transformer models, including ViT, MobileViT2, ViTMSN, and BEiT were subjected to training and validation procedures, during which hyperparameters like the learning rate and batch size were fine-tuned. The overall performance of the optimized architectures has been assessed using various performance metrics to showcase the consistent performance of the fine-tuned model. Regarding performance, ViT has shown superior performance in validation and testing accuracy and loss minimization, specifically for CT images when trained at a single epoch with a tuned learning rate of 0.0001. The results were as follows: validation accuracy of 99.85%, testing accuracy of 100%, training loss of 0.0075, and validation loss of 0.0047. The experimental evaluation of the independently collected data gives empirical evidence that the optimized Vision Transformer (ViT) architecture exhibited superior performance compared to all other optimized architectures. It achieved a flawless score of 1.0 in various standard performance metrics, including Sensitivity, Specificity, Accuracy, F1-score, Precision, Recall, Mathew Correlation Coefficient (MCC), Precision-Recall Area under the Curve (AUC PR), Receiver Operating Characteristic and Area Under the Curve (ROC-AUC). Therefore, the optimized Vision Transformer (ViT) functions as a reliable diagnostic tool for the automated categorization of individuals with pulmonary fibrosis (PF) using chest computed tomography (CT) scans.

Indexed as

classificationcomputed tomography (CT)deep learningdetectionpulmonary fibrosisvision transformerViT

Identifiers

PMID38020169
PMCPMC10666764
OpenAlexW4388540735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.